Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
Steels, E, Paesmans, M, Berghmans, T, Branle, F, Lemaitre, F, Mascaux, C, Meert, A.P, Vallot, F, Lafitte, J.J, Sculier, J.P
Published in The European respiratory journal (01.10.2001)
Published in The European respiratory journal (01.10.2001)
Get full text
Journal Article
Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
Fischer, M, Wulff, B, Baruchel, S, Berlanga, P, Trahair, T, Mechinaud, F, Schulte, J, Modak, S, Merks, J.H, Zwaan, C.M, Marshall, L.V, Casanova, M, Branle, F, Malet, I, Emeremni, A.C, Geoerger, B
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
MARTIN, B, PAESMANS, M, LAFITTE, J-J, SCULIER, J-P, BERGHMANS, T, BRANLE, F, GHISDAL, L, MASCAUX, C, MEERT, A-P, STEELS, E, VALLOT, F, VERDEBOUT, J-M
Published in British journal of cancer (07.07.2003)
Published in British journal of cancer (07.07.2003)
Get full text
Journal Article
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
Mascaux, C., Paesmans, M., Berghmans, T., Branle, F., Lafitte, J.J., Lemaı̂tre, F., Meert, A.P., Vermylen, P., Sculier, J.P.
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2000)
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2000)
Get full text
Journal Article
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature
SCULIER, J. P, GHISDAL, L, MASCAUX, C, PAESMANS, M, BERGHMANS, T, BRANLE, F, LAFITTE, J. J, VALLOT, F, MEERT, A. P, LEMAITRE, F, STEELS, E, BURNIAT, A
Published in British journal of cancer (04.05.2001)
Published in British journal of cancer (04.05.2001)
Get full text
Journal Article
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
Morin, Gabriel, Degrugillier-Chopinet, Caroline, Vincent, Marie, Fraissenon, Antoine, Aubert, Hélène, Chapelle, Célia, Hoguin, Clément, Dubos, François, Catteau, Benoit, Petit, Florence, Mezel, Aurélie, Domanski, Olivia, Herbreteau, Guillaume, Alesandrini, Marie, Boddaert, Nathalie, Boutry, Nathalie, Broissand, Christine, Han, Tianxiang Kevin, Branle, Fabrice, Sarnacki, Sabine, Blanc, Thomas, Guibaud, Laurent, Canaud, Guillaume
Published in The Journal of experimental medicine (07.03.2022)
Published in The Journal of experimental medicine (07.03.2022)
Get full text
Journal Article
390O - Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Barlesi, F., Kim, D.-W., Bertino, E.M., van den Bent, M.J., Wakelee, H., Wen, P.Y., Garrido Lopez, P., Orlov, S., Majem, M., McKeage, M., Yu, C.-J., Hurtado, F.K., Cazorla Arratia, P., Song, Y., Branle, F., Shi, M., Chow, L.Q.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1473P - First-line ceritinib versus chemotherapy in patients (pts) with advanced ALK rearranged (ALK+) non-small cell lung cancer (NSCLC): ASCEND-4 Asian subgroup analysis
Tan, D.S., Geater, S., Yu, C.J., Tsai, C.M., Hsia, T.C., Zhou, J., Chen, J., Lin, M.C., Yu, P., He, J., Li, W., Lu, Y., Sriuranpong, V., Yang, C.T., Sen, P., Branle, F., Shi, M., Wu, Y.L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
First-line ceritinib versus chemotherapy in patients (pts) with advanced ALK rearranged (ALK+) non-small cell lung cancer (NSCLC): ASCEND-4 Asian subgroup analysis
Tan, D.S., Geater, S., Yu, C.J., Tsai, C.M., Hsia, T.C., Zhou, J., Chen, J., Lin, M.C., Yu, P., He, J., Li, W., Lu, Y., Sriuranpong, V., Yang, C.T., Sen, P., Branle, F., Shi, M., Wu, Y.L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Barlesi, F., Kim, D.-W., Bertino, E.M., van den Bent, M.J., Wakelee, H., Wen, P.Y., Garrido Lopez, P., Orlov, S., Majem, M., McKeage, M., Yu, C.-J., Hurtado, F.K., Cazorla Arratia, P., Song, Y., Branle, F., Shi, M., Chow, L.Q.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain
Chow, L.Q., Barlesi, F., Bertino, E.M., van den Bent, M.J., Wakelee, H., Wen, P.Y., Chiu, C.-H., Orlov, S., Majem, M., Chiari, R., McKeage, M., Yu, C.-J., Hurtado, F.K., Arratia, P Cazorla, Song, Y., Branle, F., Shi, M., Kim, D.-W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1473PFirst-line ceritinib versus chemotherapy in patients (pts) with advanced ALK rearranged (ALK+) non-small cell lung cancer (NSCLC): ASCEND-4 Asian subgroup analysis
Tan, D S, Geater, S, Yu, C J, Tsai, C M, Hsia, T C, Zhou, J, Chen, J, Lin, M C, Yu, P, He, J, Li, W, Lu, Y, Sriuranpong, V, Yang, C T, Sen, P, Branle, F, Shi, M, Wu, Y L
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
390OEfficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Barlesi, F, Kim, D -W, Bertino, E M, van den Bent, M J, Wakelee, H, Wen, P Y, Garrido Lopez, P, Orlov, S, Majem, M, McKeage, M, Yu, C -J, Hurtado, F K, Cazorla Arratia, P, Song, Y, Branle, F, Shi, M, Chow, L Q
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1478O - Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain
Chow, L.Q., Barlesi, F., Bertino, E.M., van den Bent, M.J., Wakelee, H., Wen, P.Y., Chiu, C.-H., Orlov, S., Majem, M., Chiari, R., McKeage, M., Yu, C.-J., Hurtado, F.K., Arratia, P Cazorla, Song, Y., Branle, F., Shi, M., Kim, D.-W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1478OResults of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain
Chow, L Q, Barlesi, F, Bertino, E M, van den Bent, M J, Wakelee, H, Wen, P Y, Chiu, C-H, Orlov, S, Majem, M, Chiari, R, McKeage, M, Yu, C-J, Hurtado, F K, Arratia, P Cazorla, Song, Y, Branle, F, Shi, M, Kim, D-W
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
419O Efficacy and safety of ceritinib in patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and baseline brain metastases (BM) – results from ASCEND-2 and ASCEND-3
Park, K., Tan, D., Ahn, M.-J., Yu, C.-J., Tsai, C.-M., Hida, T., Nishio, M., Branle, F., Emeremni, C., Mok, T.
Published in Annals of oncology (01.12.2015)
Published in Annals of oncology (01.12.2015)
Get full text
Journal Article
133 - Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
Fischer, M., Wulff, B., Baruchel, S., Berlanga, P., Trahair, T., Mechinaud, F., Schulte, J., Modak, S., Merks, J.H., Zwaan, C.M., Marshall, L.V., Casanova, M., Branle, F., Malet, I., Emeremni, A.C., Geoerger, B.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Ceritinib in Patients (PTS) with Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) Metastatic to the Brain and/or Leptomeninges: the Phase II Ascend-7 Study
Chow, L.Q., Barlesi, F., Bertino, E.M., Kim, D.-W., van den Bent, M.J., Wakelee, H., Wen, P.Y., Cazorla Arratia, P., Shen, J., Branle, F.
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article
MARIANNE: A phase III, randomized study of trastuzumab-DM1 (T-DM1) with or without pertuzumab (P) compared with trastuzumab (H) plus taxane for first-line treatment of HER2-positive, progressive, or recurrent locally advanced or metastatic breast cancer (MBC)
Ellis, P. A., Barrios, C. H., Im, Y., Patre, M., Branle, F., Perez, E. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Abstract P5-18-05: Interim Results from a Phase 1b/2a Study of Trastuzumab Emtansine and Docetaxel, With and Without Pertuzumab, in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer
Martin, M, García-Sáenz, JÁ, Dewar, JA, Albanell, J, Limentani, SA, Strasak, A, Patre, M, Branle, F, Fumoleau, P
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article